Sorrento Therapeutics Stock Price - SRNE

0.11 (2.67%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sorrento Therapeutics Inc SRNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.26 6.74% 4.12 4.00 4.56 4.20 3.86 00:00:00
Bid Price Ask Price Spread Spread % News
4.22 4.26 0.04 0.94% 1 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
86,330 33,729,243 $ 4.21 $ 142,004,973 47,598,182 1.39 - 10.61
Last Trade Time Type Quantity Stock Price Currency
19:59:47 formt 3,750 $ 4.23 USD

Sorrento Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 863.92M 209.69M 105.18M $ 31.43M $ - -2.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sorrento Therapeutics News

Date Time Source News Article
6/05/202009:32Edgar (US Regulatory)Current Report Filing (8-k)
6/05/202009:30PR Newswire (US)Sorrento COVIDTRAP™(STI-4398) Demonstrates in Preclinical..
6/04/202013:29PR Newswire (US)Moore Kuehn, PLLC Encourages Investors of CLNY, SRNE, and..
5/26/202009:00GlobeNewswire Inc.Sorrento Receives FDA IND Clearance to Initiate a Phase I..
5/21/202007:01Edgar (US Regulatory)Current Report Filing (8-k)
5/21/202007:00GlobeNewswire Inc.Sorrento Enters Into Binding Term Sheet to Acquire Exclusive..
5/15/202013:53Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRNE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.875.12133.824.4419,211,723-0.75-15.4%
1 Month2.6310.612.335.9669,994,2691.4956.65%
3 Months2.0010.611.555.2827,128,4292.12106.0%
6 Months3.6310.611.554.9015,702,9660.4913.5%
1 Year3.2110.611.394.629,061,4770.9128.35%
3 Years1.7010.651.394.704,335,0562.42142.35%
5 Years13.9726.801.394.922,771,278-9.85-70.51%

Sorrento Therapeutics Description

Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates.
Your Recent History
Sorrento T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200607 01:08:19